Bausch Health Companies I...

NYSE: BHC · Real-Time Price · USD
8.00
0.49 (6.52%)
At close: Aug 15, 2025, 12:33 PM

Bausch Health Companies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
9.7B 9.6B 9.52B 9.46B 9.19B 8.96B 8.76B 8.54B 8.35B 8.15B 8.12B 8.13B 8.19B 8.32B 8.43B 8.45B 8.48B 8.04B
Cost of Revenue
2.42B 3.39B 3.6B 1.06B 707.71M 367.92M 40M 2.51B 2.47B 2.4B 2.36B 2.34B 2.34B 2.37B 2.39B 2.41B 2.42B 2.3B
Gross Profit
7.28B 6.21B 5.91B 8.4B 8.48B 8.59B 8.72B 6.04B 5.88B 5.75B 5.76B 5.79B 5.86B 5.95B 6.04B 6.04B 6.06B 5.74B
Operating Income
1.6B 1.58B 1.59B 1.4B 1.09B 1.08B 963M 998M 1.23B 1.1B 1.22B 1.19B 1.51B 956M 450M 78M -36M 207M
Interest Income
40M 35M 33M 31M 30M 29M 26M 25M 22M 18M 14M 9M 8M 7M 7M 8M 8M 8M
Pretax Income
281M 188.99M 167.3M -48.7M -353.7M -322.69M -390M -740M 25M -183M -129M 249M 26M -515M -1.02B -1.44B -1.58B -1.35B
Net Income
95.38M -42.63M -48.34M 256.29M -36.71M -20.71M -166M -971M -194M -359M -216M 263M 52M -404M -948M -1.17B -1.29B -1.02B
Selling & General & Admin
3.43B 3.37B 3.29B 3.24B 3.1B 2.98B 2.92B 2.82B 2.76B 2.73B 2.63B 2.64B 2.63B 2.64B 2.62B 2.58B 2.5B 2.34B
Research & Development
621.4M 618.37M 625.69M 619.29M 611.29M 611.33M 604M 594M 574M 545M 529M 504M 492M 480M 465M 467M 449M 442M
Other Expenses
581M 578M 306M -3M -63M -61.33M 234.67M 576.67M 636.67M 940M 954M 932M 1.27B 1.87B 1.59B 962M 1.01B 549M
Operating Expenses
4.61B 4.54B 4.2B 3.84B 3.97B 4.03B 4.26B 4.49B 4.45B 4.5B 4.4B 4.41B 4.44B 5.03B 5.05B 5.03B 5B 4.47B
Interest Expense
548M 1.36B 1.39B 1.41B 1.41B 1.38B 1.33B 1.27B 1.32B 1.41B 1.46B 1.5B 1.47B 1.42B 1.43B 1.46B 1.49B 1.51B
Selling & Marketing Expenses
n/a n/a n/a 625M 625M 625M 625M 518M 518M 518M 518M 515M 515M 515M 515M 3M 3M 3M
Cost & Expenses
7.03B 7.94B 7.81B 4.91B 4.68B 4.4B 4.3B 6.99B 6.92B 6.9B 6.76B 6.75B 6.77B 7.41B 7.44B 7.44B 7.42B 6.78B
Income Tax Expense
209.57M 270.56M 239.53M -273.47M -289.05M -286.04M -221M 234M 214M 172M 83M -21M -32M -119M -87M -278M -298M -333M
Shares Outstanding (Basic)
370.9M 362.5M 372M 368.4M 367.9M 366.8M 365.24M 365.4M 364.8M 363.3M 361.9M 362.5M 362.2M 360.8M 360M 359.6M 358.43M 356.8M
Shares Outstanding (Diluted)
373.1M 362.5M 372M 368.4M 370.2M 366.8M 365.24M 365.4M 367.1M 363.3M 361.9M 363.4M 362.5M 360.8M 364.1M 364M 358.43M 363.5M
EPS (Basic)
0.26 -0.11 -0.12 0.71 -0.09 -0.05 -0.46 -2.67 -0.54 -0.99 -0.59 0.78 0.34 -0.94 -2.47 -3.14 -3.53 -2.79
EPS (Diluted)
0.26 -0.11 -0.12 0.71 -0.09 -0.05 -0.46 -2.67 -0.54 -0.99 -0.59 0.78 0.34 -0.94 -2.44 -3.11 -3.5 -2.75
EBITDA
2.22B 2.49B 2.83B 2.81B 2.47B 2.49B 2.38B 1.85B 2.25B 2.14B 2.29B 2.83B 3.06B 2.54B 2.08B 1.64B 1.62B 1.96B
EBIT
1.77B 1.56B 1.56B 1.37B 1.06B 1.06B 943.1M 537.1M 1.35B 1.22B 1.34B 1.75B 1.49B 907.17M 400.74M 21.74M -92.4M 159M
Depreciation & Amortization
624.59M 942.52M 1.27B 1.3B 1.27B 1.27B 1.27B 1.3B 1.33B 1.36B 1.4B 1.4B 1.44B 1.5B 1.55B 1.61B 1.67B 1.75B